The mechanisms governing metastatic progression in PCa are poorly understood, although recurrent genetic changes leading to PTEN and p53 inactivation and to overexpression of c-myc are often observed in advanced tumors [3,4]. This evidence concerns the gene TP53 and posterior cortical atrophy.